Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$39,070,632
+$4,661,540 QoQ
Shares Held
155,264
-1.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#426
of 4,153 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. ABBV ranks #3 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in ABBV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,070,632 | 155,264 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $34,409,092 | 158,210 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $35,897,149 | 157,106 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,753,501 | 158,735 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $29,054,356 | 156,526 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $33,905,364 | 161,824 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $27,804,363 | 156,468 | Shares | Sole | 2025-02-07 | |
| 2024-03-31 | $27,707,971 | 152,158 | Shares | Sole | 2024-05-09 | |
| 2023-06-30 | $19,853,543 | 147,358 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $23,162,995 | 145,341 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,594,413 | 145,996 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,160,220 | 150,214 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,409,605 | 146,315 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,713,937 | 146,283 | Shares | Sole | 2022-05-11 | |
| 2021-09-30 | $15,477,511 | 143,483 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,917,496 | 141,313 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $15,523,942 | 143,448 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $15,244,123 | 142,269 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $12,403,444 | 141,608 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $14,004,395 | 142,640 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||